JP2017523142A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017523142A5 JP2017523142A5 JP2016572533A JP2016572533A JP2017523142A5 JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5 JP 2016572533 A JP2016572533 A JP 2016572533A JP 2016572533 A JP2016572533 A JP 2016572533A JP 2017523142 A5 JP2017523142 A5 JP 2017523142A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- range
- surfactant
- macrogol
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3077/CHE/2014 | 2014-06-25 | ||
| IN3077CH2014 | 2014-06-25 | ||
| PCT/IN2015/000266 WO2015198350A1 (en) | 2014-06-25 | 2015-06-25 | A pharmaceutical oil-in-water nano-emulsion |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019189623A Division JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017523142A JP2017523142A (ja) | 2017-08-17 |
| JP2017523142A5 true JP2017523142A5 (https=) | 2018-07-05 |
| JP6634034B2 JP6634034B2 (ja) | 2020-01-22 |
Family
ID=54015153
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572533A Expired - Fee Related JP6634034B2 (ja) | 2014-06-25 | 2015-06-25 | 医薬水中油型ナノエマルジョン |
| JP2019189623A Pending JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019189623A Pending JP2020037557A (ja) | 2014-06-25 | 2019-10-16 | 医薬水中油型ナノエマルジョン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10736842B2 (https=) |
| EP (1) | EP3160444B1 (https=) |
| JP (2) | JP6634034B2 (https=) |
| WO (1) | WO2015198350A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006249866B2 (en) | 2005-05-26 | 2011-10-13 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
| WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
| CN117045653A (zh) | 2013-01-23 | 2023-11-14 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US11400048B2 (en) * | 2014-06-25 | 2022-08-02 | Synergia Bio Sciences Private Limited | Pharmaceutical oil-in-water nano-emulsion |
| US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
| CA3022665A1 (en) | 2016-05-09 | 2017-11-16 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
| JP7518604B2 (ja) * | 2016-06-07 | 2024-07-18 | タルガジェニックス，インコーポレイテッド | タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 |
| NZ752750A (en) | 2016-11-02 | 2023-05-26 | Centrexion Therapeutics Corp | Stable aqueous capsaicin injectable formulations and medical uses thereof |
| PL3558269T3 (pl) * | 2016-12-21 | 2024-11-18 | Dukebox Spółka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania emulsji woda w oleju nanocząsteczek paracetamolu |
| ES3018268T3 (en) | 2017-07-20 | 2025-05-14 | Centrexion Therapeutics Corp | Compositions and their use for treatment of pain using capsaicin |
| WO2019075136A1 (en) | 2017-10-10 | 2019-04-18 | Aldeyra Therapeutics, Inc. | TREATMENT OF INFLAMMATORY DISORDERS |
| BR112020013750A8 (pt) * | 2018-01-05 | 2022-10-18 | Impel Neuropharma Inc | Dispensação intranasal de olanzapina por dispositivo olfativo de precisão |
| JP7385881B2 (ja) * | 2018-07-18 | 2023-11-24 | テクノガード株式会社 | オキシカム系薬物含有注射剤 |
| WO2020028820A1 (en) * | 2018-08-03 | 2020-02-06 | Aldeyra Therapeutics, Inc. | Topical compositions and methods of preparation and use |
| AU2019319740A1 (en) | 2018-08-06 | 2021-03-25 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| US11690963B2 (en) | 2018-08-22 | 2023-07-04 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| US11517685B2 (en) | 2019-01-18 | 2022-12-06 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| US12501929B2 (en) | 2018-08-22 | 2025-12-23 | Qnovia, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| WO2020041641A1 (en) | 2018-08-22 | 2020-02-27 | Respira Technologies, Inc. | Electronic device for producing an aerosol for inhalation by a person |
| WO2020106979A1 (en) * | 2018-11-21 | 2020-05-28 | Bocannaveda, Llc | Nano-emulsified cannabinoid or oils in athletic tape and other products |
| CN113365590A (zh) * | 2018-11-21 | 2021-09-07 | 博坎纳维达有限责任公司 | 透气带及其它产品中的经纳米乳化的大麻素或油 |
| GB201904771D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| JP2022530967A (ja) | 2019-05-02 | 2022-07-05 | アルデイラ セラピューティクス， インコーポレイテッド | 多形化合物およびその使用 |
| WO2020223717A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| EP3982930A1 (en) * | 2019-06-11 | 2022-04-20 | SIFI S.p.A. | Microemulsion compositions |
| WO2021081010A1 (en) * | 2019-10-20 | 2021-04-29 | Respira Technologies, Inc. | Liquids for aerosolizing and inhaling using electronic devices |
| US20210113783A1 (en) * | 2019-10-20 | 2021-04-22 | Respira Technologies, Inc. | Electronic devices and liquids for aerosolizing and inhaling therewith |
| WO2021231792A1 (en) | 2020-05-13 | 2021-11-18 | Aldeyra Therapeutics, Inc. | Pharmaceutical formulations and uses thereof |
| US12471625B2 (en) | 2020-11-01 | 2025-11-18 | Qnovia, Inc. | Electronic devices and liquids for aerosolizing and inhaling therewith |
| FR3120787B1 (fr) * | 2021-03-19 | 2024-04-26 | Algotherapeutix | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline |
| US12279650B2 (en) | 2022-04-22 | 2025-04-22 | Qnovia, Inc. | Electronic devices for aerosolizing and inhaling liquid having an enclosed interior air passageway with diaphragm and pressure sensor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646773B1 (fr) * | 1989-05-12 | 1994-05-13 | Chauvin Sa Laboratoire | Composition pharmaceutique a base de paracetamol |
| US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
| CZ298398A3 (cs) | 1996-03-25 | 1999-06-16 | Eli Lilly And Company | Farmaceutický přípravek |
| WO1999029316A1 (en) * | 1997-12-10 | 1999-06-17 | Severson, Mary, L. | Pharmaceutical compositions containing an omega-3 fatty acid oil |
| CA2331640A1 (en) * | 1998-05-07 | 1999-11-11 | Elan Corporation Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| GB9823246D0 (en) | 1998-10-24 | 1998-12-16 | Danbiosyst Uk | A nasal drug delivery composition |
| US20030044356A1 (en) * | 2001-04-20 | 2003-03-06 | Jin Auh | Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one) |
| GB0116107D0 (en) | 2001-06-30 | 2001-08-22 | West Pharm Serv Drug Res Ltd | Pharmaceutical composition |
| KR100425755B1 (ko) | 2001-08-27 | 2004-04-03 | 주식회사 원진신약 | 이트라코나졸을 함유하는 조성물 및 그 제조방법 |
| IL164163A0 (en) | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
| US20060210500A1 (en) * | 2003-04-18 | 2006-09-21 | Merck Patent Gmbh | Formulations |
| IL181217A0 (en) * | 2007-02-08 | 2007-07-04 | Haim Levy | Pharmaceuticalcompositions based on a microemulsion |
| CN101524329B (zh) | 2007-09-20 | 2014-09-03 | 中国医学科学院药物研究所 | 双环醇亚微乳及其制备方法 |
| CN101780037B (zh) | 2010-02-03 | 2011-11-16 | 南昌大学 | 双嘧达莫自乳化给药系统及其制备方法 |
-
2015
- 2015-06-25 WO PCT/IN2015/000266 patent/WO2015198350A1/en not_active Ceased
- 2015-06-25 EP EP15757010.2A patent/EP3160444B1/en active Active
- 2015-06-25 JP JP2016572533A patent/JP6634034B2/ja not_active Expired - Fee Related
- 2015-06-25 US US15/309,716 patent/US10736842B2/en active Active
-
2019
- 2019-10-16 JP JP2019189623A patent/JP2020037557A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017523142A5 (https=) | ||
| US11020375B2 (en) | Edaravone dosage form | |
| JP5726067B2 (ja) | 難透過性医薬品活性成分のための改善された製剤 | |
| JP6670283B2 (ja) | タペンタドールを含む半固形の水性医薬組成物 | |
| JP2020037557A (ja) | 医薬水中油型ナノエマルジョン | |
| JP5966228B2 (ja) | アリピプラゾール組成物 | |
| US12558321B2 (en) | Pharmaceutical formulation | |
| EP3481381B1 (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
| CN1543359A (zh) | 可生物利用的口服剂型醋氯芬酸组合物及其制备方法 | |
| US10973761B2 (en) | Pharmaceutical formulation | |
| CN1642537A (zh) | 用于硬壳胶囊的布洛芬溶液 | |
| TW200840596A (en) | Microemulsion dosage forms of valsartan and methods of making the same | |
| US20250032520A1 (en) | Oral cannabinoid compositions and methods for treating neurological diseases and disorders | |
| CN106727382A (zh) | 一种卡维地洛过饱和自微乳分散片及其制备方法 | |
| JP5503939B2 (ja) | アゼラスチン塩酸塩含有カプセル剤 | |
| EP3135299A1 (en) | Active ingredient (i) containing composition and method for preparing same | |
| KR20250129103A (ko) | 자가유화 약학적 조성물, 그 제조 방법 및 그 용도 | |
| JP2017518980A (ja) | タペンタドールを含む、改変防止即時放出カプセル製剤 | |
| Pires et al. | Antipsychotics-loaded Nanometric emulsions for brain delivery. Pharmaceutics. 2022; 14: 2174 | |
| HK40129772A (en) | Edaravone dosage form | |
| CN121969362A (zh) | 大麻素的口服制剂 | |
| TR2021012699A2 (tr) | Cannabi̇di̇olün nazal uygulanan kolloi̇dal formülasyonlari | |
| HK40008934B (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
| TW200936128A (en) | Pharmaceutical compositions based on azetidine derivatives |